• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鼻咽拭子和口咽拭子检测的PCR敏感性:一项比较研究。

PCR sensitivity for detection in nasopharyngeal and oropharyngeal swabs: a comparative study.

作者信息

Kitagawa Daisuke, Nishihara Shin, Murata Masayuki, Onishi Mai, Mori Takahiro, Hachisuka Soshi, Okubo Tenshin, Yamamoto Naohiro, Nishikawa Hiroki, Onaka Masayuki, Suzuki Rika, Suzuki Soma, Yamamoto Ayu, Uejima Ritsuki, Nakamura Fumihiko, Yoshida Sayaka, Kitano Taito

机构信息

Department of Laboratory Medicine, Nara Prefecture General Medical Center, Nara, Japan.

Sukusuku Kid's Clinic, Nara, Japan.

出版信息

J Clin Microbiol. 2025 Aug 13;63(8):e0045825. doi: 10.1128/jcm.00458-25. Epub 2025 Jul 3.

DOI:10.1128/jcm.00458-25
PMID:40608326
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12345179/
Abstract

The differential impact of sample type on polymerase chain reaction (PCR) detection of (MP) has rarely been investigated. The study aimed to evaluate the diagnostic performance of PCR for the detection of MP and to measure MP DNA load between nasopharyngeal and oropharyngeal swabs. Nasopharyngeal and oropharyngeal samples were obtained simultaneously to evaluate their diagnostic performance in children with suspected MP. Two commercially available PCR tests, multiplex PCR and Smart Gene Myco, were used to analyze the nasopharyngeal and oropharyngeal samples, respectively. Furthermore, real-time PCR (RT-PCR) tests were conducted on both sample residues to validate the results. In total, 422 participants underwent simultaneous PCR testing using nasopharyngeal and oropharyngeal swabs; 139 samples (32.9%) from nasopharyngeal swabs and 176 samples (41.7%) from oropharyngeal samples that tested positive using commercially available tests. RT-PCR tests were positive for 136 (32.2%) nasopharyngeal and 183 (43.4%) oropharyngeal residual samples. With the RT-PCR test of the residual extract from oropharyngeal swabs as a reference, the sensitivity and specificity of detecting MP were 74.9% (95% confidence interval 67.9%-81.0%) and 99.2% (97.0%-99.9%) with the multiplex PCR test on nasopharyngeal swabs, and 96.2% (92.3%-98.4%) and 100.0% (98.5%-100.0%) with the Smart Gene Myco on oropharyngeal samples. A negative correlation was observed between fluoroquinolone use and oropharyngeal DNA loads ( = 0.004). The sensitivity of MP detection was significantly better in oropharyngeal samples than in nasopharyngeal samples. This study indicates that oropharyngeal samples should be used to detect MP rather than nasopharyngeal samples.IMPORTANCEObtaining the best sample is crucial for the accurate diagnosis of (MP) and timely and appropriate treatment. This study aimed to assess the diagnostic performance of MP detection using polymerase chain reaction (PCR) tests between nasopharyngeal and oropharyngeal samples. This study showed that the sensitivity of detecting MP was 74.9% (95% confidence interval 67.9%-81.0%) with a commercially available PCR test on nasopharyngeal swabs, and 96.2% (92.3%-98.4%) with a commercially available PCR test on oropharyngeal samples. The sensitivity of MP detection was significantly better in oropharyngeal samples than in nasopharyngeal samples. This study supports the idea that oropharyngeal samples should be used to detect MP. The results contribute to guidance in the recommendation regarding sampling methods to detect MP. Accurate identification of MP is crucial not only for timely and appropriate antimicrobial treatment but also for efficient epidemiological surveillance.

摘要

样本类型对聚合酶链反应(PCR)检测肺炎支原体(MP)的差异影响鲜有研究。本研究旨在评估PCR检测MP的诊断性能,并测量鼻咽拭子和口咽拭子之间的MP DNA载量。同时采集鼻咽和口咽样本,以评估其在疑似MP儿童中的诊断性能。分别使用两种市售PCR检测方法,即多重PCR和Smart Gene Myco,对鼻咽和口咽样本进行分析。此外,对两份样本的残余物进行实时PCR(RT-PCR)检测以验证结果。共有422名参与者同时使用鼻咽拭子和口咽拭子进行PCR检测;使用市售检测方法时,鼻咽拭子样本中有139份(32.9%)呈阳性,口咽样本中有176份(41.7%)呈阳性。RT-PCR检测显示,鼻咽残余样本中有136份(32.2%)呈阳性,口咽残余样本中有183份(43.4%)呈阳性。以口咽拭子残余提取物的RT-PCR检测结果为参照,鼻咽拭子多重PCR检测法检测MP的灵敏度和特异性分别为74.9%(95%置信区间67.9%-81.0%)和99.2%(97.0%-99.9%),口咽样本Smart Gene Myco检测法的灵敏度和特异性分别为96.2%(92.3%-98.4%)和100.0%(98.5%-100.0%)。观察到氟喹诺酮类药物使用与口咽DNA载量之间呈负相关(P = 0.004)。口咽样本中MP检测的灵敏度显著高于鼻咽样本。本研究表明,应使用口咽样本而非鼻咽样本检测MP。

重要性

获取最佳样本对于准确诊断肺炎支原体(MP)以及及时、恰当治疗至关重要。本研究旨在评估使用聚合酶链反应(PCR)检测法在鼻咽和口咽样本中检测MP的诊断性能。本研究表明,使用市售PCR检测法检测鼻咽拭子时,检测MP的灵敏度为74.9%(95%置信区间67.9%-81.0%),检测口咽样本时为96.2%(92.3%-98.4%)。口咽样本中MP检测的灵敏度显著高于鼻咽样本。本研究支持应使用口咽样本检测MP这一观点。研究结果有助于为检测MP的采样方法推荐提供指导。准确鉴定MP不仅对于及时、恰当的抗菌治疗至关重要,而且对于有效的流行病学监测也至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b145/12345179/4f6b6de3af5e/jcm.00458-25.f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b145/12345179/b3216f118240/jcm.00458-25.f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b145/12345179/4f6b6de3af5e/jcm.00458-25.f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b145/12345179/b3216f118240/jcm.00458-25.f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b145/12345179/4f6b6de3af5e/jcm.00458-25.f002.jpg

相似文献

1
PCR sensitivity for detection in nasopharyngeal and oropharyngeal swabs: a comparative study.鼻咽拭子和口咽拭子检测的PCR敏感性:一项比较研究。
J Clin Microbiol. 2025 Aug 13;63(8):e0045825. doi: 10.1128/jcm.00458-25. Epub 2025 Jul 3.
2
The effect of sample site and collection procedure on identification of SARS-CoV-2 infection.样本采集部位和采集程序对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染鉴定的影响。
Cochrane Database Syst Rev. 2024 Dec 16;12(12):CD014780. doi: 10.1002/14651858.CD014780.
3
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原检测。
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.
4
Laboratory-based molecular test alternatives to RT-PCR for the diagnosis of SARS-CoV-2 infection.基于实验室的分子检测替代 RT-PCR 用于 SARS-CoV-2 感染的诊断。
Cochrane Database Syst Rev. 2024 Oct 14;10(10):CD015618. doi: 10.1002/14651858.CD015618.
5
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
6
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
7
Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma.染色体臂 1p 和 19q 缺失的检测在胶质瘤患者中的诊断准确性和成本效益。
Cochrane Database Syst Rev. 2022 Mar 2;3(3):CD013387. doi: 10.1002/14651858.CD013387.pub2.
8
The correlation between positive rate of antibody or DNA and children's age with suspected Mycoplasma pneumoniae infection.疑似肺炎支原体感染患儿抗体或DNA阳性率与年龄的相关性
Ital J Pediatr. 2025 May 28;51(1):156. doi: 10.1186/s13052-025-01993-x.
9
Colorimetric RT-LAMP for SARS-CoV-2 detection from nasopharyngeal swabs or crude saliva: a multicountry diagnostic accuracy study in Africa.用于从鼻咽拭子或未经处理的唾液中检测新型冠状病毒的比色逆转录环介导等温扩增技术:一项在非洲开展的多国诊断准确性研究
Lancet Glob Health. 2025 Jul;13(7):e1258-e1267. doi: 10.1016/S2214-109X(25)00150-0.
10
Implementation of a Laboratory-Developed Test for the Diagnosis of Using a High-Throughput Approach.采用高通量方法实施用于诊断的实验室自建检测方法。
Pathogens. 2025 Jul 14;14(7):692. doi: 10.3390/pathogens14070692.

本文引用的文献

1
Bactericidal versus bacteriostatic antibacterials: clinical significance, differences and synergistic potential in clinical practice.杀菌性与抑菌性抗菌药物:临床意义、差异及临床实践中的协同潜力
J Antimicrob Chemother. 2025 Jan 3;80(1):1-17. doi: 10.1093/jac/dkae380.
2
Reduced sensitivity of a multiplex commercial respiratory panel for detection of is due to specimen type.一种用于检测的多重商用呼吸道检测板灵敏度降低是由于样本类型所致。
J Clin Microbiol. 2024 Oct 16;62(10):e0113924. doi: 10.1128/jcm.01139-24. Epub 2024 Sep 10.
3
Insight into the Pathogenic Mechanism of Mycoplasma pneumoniae.
探讨肺炎支原体的致病机制。
Curr Microbiol. 2022 Dec 2;80(1):14. doi: 10.1007/s00284-022-03103-0.
4
Correlation between Mycoplasma pneumoniae drug resistance and clinical characteristics in bronchoalveolar lavage fluid of children with refractory Mycoplasma pneumoniae pneumonia.肺炎支原体耐药性与儿童难治性肺炎支原体肺炎支气管肺泡灌洗液临床特征的相关性。
Ital J Pediatr. 2022 Nov 26;48(1):190. doi: 10.1186/s13052-022-01376-6.
5
Global Trends in the Proportion of Macrolide-Resistant Mycoplasma pneumoniae Infections: A Systematic Review and Meta-analysis.全球大环内酯类耐药肺炎支原体感染比例的趋势:系统评价和荟萃分析。
JAMA Netw Open. 2022 Jul 1;5(7):e2220949. doi: 10.1001/jamanetworkopen.2022.20949.
6
Point-of-care molecular diagnosis of Mycoplasma pneumoniae including macrolide sensitivity using quenching probe polymerase chain reaction.即时检测肺炎支原体的分子诊断,包括使用荧光淬灭探针聚合酶链反应检测大环内酯类药物敏感性。
PLoS One. 2021 Oct 14;16(10):e0258694. doi: 10.1371/journal.pone.0258694. eCollection 2021.
7
Pneumonia.肺炎。
Nat Rev Dis Primers. 2021 Apr 8;7(1):25. doi: 10.1038/s41572-021-00259-0.
8
C values from SARS-CoV-2 diagnostic PCR assays should not be used as direct estimates of viral load.来自新冠病毒诊断性PCR检测的C值不应被用作病毒载量的直接估计值。
J Infect. 2021 Mar;82(3):414-451. doi: 10.1016/j.jinf.2020.10.017. Epub 2020 Oct 24.
9
Epidemiology of macrolide-resistant Mycoplasma pneumoniae by age distribution in Japan.日本按年龄分布的大环内酯类耐药肺炎支原体流行病学。
J Infect Chemother. 2021 Jan;27(1):45-48. doi: 10.1016/j.jiac.2020.08.006. Epub 2020 Aug 28.
10
The utility of beta-2-microglobulin testing as a human cellular control in COVID-19 testing.β2微球蛋白检测作为新冠病毒检测中人类细胞对照的效用。
J Clin Virol. 2020 Aug;129:104449. doi: 10.1016/j.jcv.2020.104449. Epub 2020 May 20.